Atropine is a medication used to treat anticholinesterase poisoning, AV heart block, bradyarrhythmia, and organophosphate poisoning. Atropine suppliers market the drug in the form of ophthalmic drops, solutions for injection and tablets.
Atropine is one of the drugs included by the WHO in its list of Essential Medicines, which is made up of the safest and most effective drugs recommended for a health system. The market for the drug is relatively fragmented and populated by a multitude of atropine manufacturers and suppliers, which are mostly concentrated in North America and Europe. The largest atropine manufacturers are companies C2Pharma, Resonance Laboratories, and Rolabo Outsourcing.
Most atropine suppliers and distributors market the drug in generic formulations. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified atropine manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The costs of atropine are considerably low. The retail prices per 1ml of a 1mg/ml atropine injectable solution fall into an approximate range of 5,00 EUR to 10,00 EUR.